以岭药业(002603.SZ)：盐酸伐昔洛韦片取得药品注册证书

Core Viewpoint - Yiling Pharmaceutical's wholly-owned subsidiary, Yiling Wanzhou International Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the marketing authorization application of Valaciclovir Hydrochloride Tablets, obtaining the drug registration certificate [1] Group 1 - Yiling Wanzhou has submitted a marketing authorization application for Valaciclovir Hydrochloride Tablets [1] - The approval from the National Medical Products Administration signifies a key milestone for the company [1] - The drug registration certificate allows the company to proceed with the commercialization of the product [1]